- Company List - O
- VITA
Insider Trading activities at Orthovita Inc (VITA)
Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Orthovita Inc (VITA)
since 2007 are illustrated in Table 1 and Table 2.
Table 1 shows the monthly insider trading data at Orthovita Inc.
Table 2 shows the detailed insider transactions.
The reporting company's CIK number is 913756.
Total stock buying since 2007: $887,217.
Total stock sales since 2007: $0.
Total stock option exercises since 2007: $237,200.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Table 1. Yearly summary of insider stock purchases, sales, and option exercises
at Orthovita Inc (VITA).
|
Insider Buying |
Insider Sales |
Option Exercises |
| Year |
Shares | Value |
Shares | Value |
Shares | Value |
| 2009 | 105,000 | $350,621 | 0 | $0 | 65,000 | $237,200 |
| 2008 | 178,692 | $398,516 | 0 | $0 | 0 | $0 |
| 2007 | 48,951 | $138,080 | 0 | $0 | 0 | $0 |
Table 2. Monthly summary of insider trading at Orthovita Inc (VITA).
| Trading Period |
Insider Buying |
Insider Sales |
Option Exercises |
| year-month |
Shares | Value |
Shares | Value |
Shares | Value |
| 2009-11 | 5,000 | $19,400 | 0 | $0 | 0 | $0 |
| 2009-07 | 0 | $0 | 0 | $0 | 50,000 | $200,000 |
| 2009-05 | 100,000 | $331,221 | 0 | $0 | 15,000 | $37,200 |
| 2008-11 | 11,372 | $26,985 | 0 | $0 | 0 | $0 |
| 2008-10 | 152,070 | $339,492 | 0 | $0 | 0 | $0 |
| 2008-05 | 15,250 | $32,039 | 0 | $0 | 0 | $0 |
| 2007-09 | 9,000 | $22,548 | 0 | $0 | 0 | $0 |
| 2007-05 | 39,951 | $115,532 | 0 | $0 | 0 | $0 |
Table 3. Detailed insider trading at Orthovita Inc (VITA)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2009-11-09 | Broadbent Nancy C (Senior VP and CFO) | Buy | 5,000 | 3.88 | 19,400 |
| 2009-07-29 | Persenaire Maarten (Chief Medical Officer) | Option Ex | 50,000 | 4.00 | 200,000 |
| 2009-05-27 | Broadbent Nancy C (Senior VP and CFO) | Buy | 39,000 | 3.34 | 130,104 |
| 2009-05-26 | Broadbent Nancy C (Senior VP and CFO) | Buy | 61,000 | 3.30 | 201,117 |
| 2009-05-14 | Persenaire Maarten (Chief Medical Officer) | Option Ex | 15,000 | 2.48 | 37,200 |
| 2008-11-20 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 11,372 | 2.37 | 26,985 |
| 2008-10-28 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 1,500 | 2.28 | 3,415 |
| 2008-10-27 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 8,900 | 2.27 | 20,176 |
| 2008-10-24 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 15,000 | 2.24 | 33,570 |
| 2008-10-22 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 2,500 | 2.28 | 5,699 |
| 2008-10-16 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 13,800 | 2.25 | 31,105 |
| 2008-10-13 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 5,670 | 2.28 | 12,904 |
| 2008-10-10 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 35,000 | 2.06 | 72,135 |
| 2008-10-09 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 25,000 | 2.25 | 56,299 |
| 2008-10-08 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 10,000 | 2.29 | 22,910 |
| 2008-10-07 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 10,000 | 2.36 | 23,590 |
| 2008-10-06 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 15,000 | 2.31 | 34,680 |
| 2008-10-03 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 8,500 | 2.37 | 20,153 |
| 2008-10-02 | Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) | Buy | 1,200 | 2.38 | 2,856 |
| 2008-05-29 | Jennings William Patrick Jr (Other) | Buy | 500 | 2.30 | 1,150 |
| 2008-05-15 | Touhey Paul (Director) | Buy | 10,000 | 2.15 | 21,549 |
| 2008-05-12 | Barry Scott (Director) | Buy | 3,750 | 1.96 | 7,350 |
| 2008-05-12 | Jennings William Patrick Jr (Other) | Buy | 1,000 | 1.99 | 1,990 |
| 2007-09-14 | Smith Christopher H (Senior VP-US Sales) | Buy | 2,000 | 2.52 | 5,038 |
| 2007-09-14 | Persenaire Maarten (Chief Medical Officer) | Buy | 2,000 | 2.52 | 5,040 |
| 2007-09-14 | Koblish Antony (President & CEO) | Buy | 5,000 | 2.49 | 12,470 |
| 2007-05-30 | Smith Christopher H (Senior VP-US Sales) | Buy | 3,000 | 2.79 | 8,385 |
| 2007-05-25 | Smith Christopher H (Senior VP-US Sales) | Buy | 5,451 | 2.87 | 15,644 |
| 2007-05-23 | Fitzgerald David (Director) | Buy | 5,000 | 2.87 | 14,350 |
| 2007-05-10 | Touhey Paul (Director) | Buy | 10,000 | 2.91 | 29,100 |
| 2007-05-10 | Pavucek Albert J Jr (Chief Financial Officer) | Buy | 5,000 | 2.89 | 14,450 |
| 2007-05-10 | Koblish Antony (President & CEO) | Buy | 11,500 | 2.92 | 33,603 |
Insider trading activities including stock purchases, stock sales, and option exercises
of VITA listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Orthovita Inc (symbol VITA,
CIK number 913756) see
the Securities and Exchange Commission (SEC) website.